Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Neoplasms × cobimetinib × Clear all

Phase

Status

Terminated 3 Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 14 Neoplasms 6 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Noonan Syndrome 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 Microsatellite Unstable Colorectal Cancer 1 Lung Neoplasms 1 Lung Diseases 1 Leukemia, Myeloid, Acute 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1

Interventions

Trastuzumab 318 Paclitaxel 299 Cyclophosphamide 280 Docetaxel 258 Capecitabine 168 Doxorubicin 159 Letrozole 153 Tamoxifen 133 Bevacizumab 109 Fulvestrant 107 Lapatinib 105 Carboplatin 101 exemestane 100 Anastrozole 100 Radiotherapy 96 Gemcitabine 90 Epirubicin 89 palbociclib 73 Vinorelbine 69 Fluorouracil 66 Surveys and Questionnaires 64 Exercise 64 pertuzumab 59 Albumin-Bound Paclitaxel 58 Filgrastim 56 Magnetic Resonance Spectroscopy 54 eribulin 52 Everolimus 49 Blood Specimen Collection 46 Taxes 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03395899 2024-06-18

ECLIPSE

Queen Mary University of London

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡